Skip to main content

Table 6 Cost-effectiveness for diagnosing and treating malaria per 100 eligible children from de societal perspective in 2014 (US$)

From: Cost-effectiveness analysis of the national implementation of integrated community case management and community-based health planning and services in Ghana for the treatment of malaria, diarrhoea and pneumonia

Variables

Volta Region

Northern Region

iCCM

CHPS

iCCM

CHPS

Number of eligible children for treatment

100

100

 

100

Number treated with ACT or quininea

24

19

 

30

Number treated with prompt ACT or quinine

17

4

 

23

Number treated according to protocol (ACT or quinine)

28

30

 

35

Number treated according to protocol (prompt ACT or quinine)

21

15

 

27

Costs per 100 children (ACT or quinine)

US$119.04

US$182.30

 

US$244.57

Cost per child treated according to protocol (ACT or quinine)

US$4.25

US$6.12

 

US$7.09

Cost per child treated according to protocol (prompt ACT or quinine)

US$5.58

US$12.24

 

US$8.92

Incremental costs per 100 children (ACT or quinine)

US$63.26

   

Incremental effect per 100 children (ACT or quinine)

2

   

Incremental cost-effectiveness ratio (ACT or quinine)

iCCM is less costly and less effective

Incremental costs per 100 children (prompt ACT or quinine)

US$63.26

   

Incremental effect per 100 children (prompt ACT or quinine)

6

   

Incremental cost-effectiveness ratio (prompt ACT or quinine)

iCCM is dominant

  1. a Source Additional file 1